Bazı Yeni 2-Pirazolin Türevlerinin Sentezi ve Monoamin Oksidaz (Mao) İnhibitör Aktiviteleri Üzerinde Çalışmalar
Özet
In this study, forty two compounds which have 1-[2-(5-substituted-2-
benzoxazolinone-3-yl)acetyl]-3,5-disubstitutedphenyl-4,5-dihydro-1H-pyrazole
structure and nine compounds which have N’-(1,3-disubstitutedphenylallylidene)-2-
(5-substituted-2-benzoxazolinone-3-yl)acetohydrazide structure have been
synthesized, structures of the compounds have been proved by spectral techniques,
their purity have been checked by elemental analyses and their interactions with
MAO-A/MAO-B isoforms have been investigted by molecular docking. MAO
inhibitory activities and selectivities of the compounds have been determined by in
vitro tests using human MAO-A and -B isoforms. Compound 6 has been seperated
to its enantiomers by analytical high pressure liquid chromatograpy (HPLC),
fractions have been collected by semipreparative HPLC, the spesific rotations have
been found and the absolute configurations have been determined by vibrational
circular dichroism (VCD) technique. It was found that R isomer is more active than S
isomer in terms of MAO-A inhibition. Following that, acute and subchronic
antidepressant effects of five compounds have been evaluated via Porsolt’s forced
swimming test (PFST) on mice. After the in vivo tests, brain tissues of the mice were
isolated and level of the serotonine, dopamine (DA) and their metabolites were
determined in brain tissues. Contrary to expectations, compounds increased the DA
level. It was thought that, this was result from the screening dose (30 mg/kg) was
relatively high and for this reason dose-response studies were done to determine the
efficient selective dose. Additionally, open field test was done to assess whether the
increase on DA level has effected the locomotor activities of mice and PFST results
indirectly.